• Human embryonic stem cells plated at low density: stained for the cell surface marker with Man7. Image courtesy of Alan Kerby and Sue Kimber.
  • Transverse histological section of healthy mouse muscle, stained with antibody antidystrophin (red), anti-laminin (green). Nuclei are stained in blue with DA.Image Courtesy of G. Cossu.
  • Transverse histological section of a mouse embryo stained with an antibody anti-PW1 (green), anti-Pax3 )(red). Nuclei are stained in blue with DAPI. Image courtesy of G. Cossu.
  • Immunohistochemistry staining of wounded skin for Keratin 6 (K6); image courtesy of Davis Ansell and Ralf Paus.
  • Adipose derived stem cells differentiated towards Schwann cells. Image courtesy of A. Reid.
  • Cultured Mesoangioblasts differentiated into Myotubes. Image courtesy of F. Galli.

MaRM Network@MaRMNetwork1

Mission statement

Regenerative medicine aims to repair, replace or regenerate damaged tissues, using cell, or gene therapy and tissue engineering. This, however, requires a multidisciplinary approach, bringing together biologists, material scientists, bioengineers and clinicians in order to translate basic biological research into viable clinical therapies. Building on our critical mass of internationally renowned leaders in the Life, Clinical and Material sciences, we are breaking down these barriers by creating an integrated framework across Manchester which will:

  1. Bring together basic scientists from the different disciplines to enhance the University’s capacity in Regenerative Medicine and enable strategic multidisciplinary grant bids.
  3. Help basic scientist move their projects into clinical protocols by creating links with clinicians interested in translating new cell, gene and bioengineering protocols to the clinic.


To facilitate and accelerate the “Bench to Bedside” movement of regenerative therapies, in addition to fostering the development of novel Regenerative Medicine technologies, we provide the following resources to researchers and clinicians:

Research topics